Washington diary: Body shock

I have spent the past two weeks recovering from foot surgery and so I have had ample time to reflect on the marvels of (private) US health care and the misery of a body in decline.

By sheer coincidence my medical issues started as soon as I landed in the US four years ago.

Only 48 hours after getting off the plane in Washington I was seized by numbing pain in my upper jaw and rushed to a smart dental clinic near the White House.

I pointed to a throbbing molar and was puzzled to find the unusually monosyllabic nurse taking an X-ray of every single tooth in my mouth with quiet and unflinching determination.

She returned half an hour later with the maestro of the clinic who pinned 36 or so stamp sized X-rays on a back-lit board as if they were part of an avant-garde art project and then gave a PowerPoint presentation entitled something like "My vision for your mouth".

"What about the tooth that hurts?" I asked innocently.

"Thas juss the beginning," said Dr Harrison, a southern gent with a pencil-thin moustache arching over a blindingly white smile.

"We are gonna work together for three years to get everything in perfect order! An I promise, I won't have to see ya more than once a month."

When the doctor had exited in a swoosh of fluttering white to "work with" the next patient, the nurse leant over as if in deep confidence and added: "You are SOOO lucky to be working with Dr Harrison! He is the beeeast!", making "best" sound like "beast".

I never returned after my root canal operation. I chose to become a dental fugitive, hounded every six weeks by increasingly urgent letters reminding me of the doctor's vision and my empty promises. I am certain that my mouth is on a blacklist somewhere.

Flatulent joints

Two months later the next chapter of bodily woes was opened. One day, out of the blue, without warning and for no apparent reason, my neck felt as if I had survived a garrotting.

I ventured into the hitherto unknown world of chiropractors.

Dr Schweinstein X-rayed everything above my shoulders and explained to me that - among other things - I had too much gas in my joints, which is why I would soon hear a flatulent noise as he took my neck into a half nelson.

As I contemplated the notion of farting joints, the chiropractor's fleshy hands fastened around my head, yanking it left and then right as if I was an extra in some martial arts movie. I heard the advertised noise and felt instantly better as the pain seeped away.

"Thank you, Dr Schweinstein," I said with genuine relief and admiration for the healing profession. "That will be it then?" I added for good measure, heading for the door.

The doctor fixed me with watery blue eyes.

"Actually," he intoned with a flat, yet authoritative voice, "this is just the prologue, you might say. What I have in mind for you is a two-year programme… a standard course of chiro-therapy to get your neck back in shape. The good news is: shouldn't need you here more than once a week! Your insurance should cover some, if not most of it."

The cost of this healing process to the uninsured would have been $150 a week. I wondered how the estimated 50m Americans who have no private medical insurance cope. They don't, of course.

But they weren't on my mind at this stage. I was planning another getaway. A fugitive from medicine… twice over.

Midlife crisis

Four months later I was reading the New York Times and my then seven-year-old son asked me: "Dad, why are you holding the newspaper like that?"

"Like what?"

"Like that… so far!" he said and stretched his little arms straight out.

I hadn't even noticed how my reading arm had got longer and longer.

So my eyes were next. At least the optician was a "walk-in". No appointments, no waiting room, no dog-eared copies of last month's Time Magazine and Yachting Monthly.

The verdict: long sighted.

"Why?" I asked the optician, whose name escapes me. "I have always had perfect vision!"

His nose crinkled and I knew I should have kept my mouth shut. No optician believes in perfect vision. It's presumptuous and it's not good for business.

"How old are you?" he asked.

"Forty-one," I replied.

"Ahhhhh," he said in a voice oozing pity, understanding and wisdom all coated in glee. "It's the age."

And with those three words my midlife crisis started.

The healthcare industry had officially declared me fair game, easy prey, a rich seam of never-ending profits.

I left the opticians and stumbled, diminished, into the glare of a Washington summer's day.

I walked down the road fingering my new glasses - frames so sleek, lenses so petite they were almost invisible - almost - when I felt my Blackberry buzz to life in my trouser pocket.

I put on my new specs clumsily, half enjoying this pompous new prop, and allowed them to slide professorially to the tip of my nose. I glanced down at the tiny screen. It was a joy to see so clearly.

An e-mail flashed up from someone called Kevin. I assumed it was work and clicked to open.

"Need Viagra, Cialis, Levitra?" Kevin asked. "We can help! You can perform!" It wasn't the Kevin I thought it was.

Metatarsal hell

I had hit rock-bottom. What could possibly be next? A few months later I got the answer: my feet.

I have always had feet so wide they defied even the most comfy Hush Puppies. To me, Birkenstocks felt like winkle-pickers.

The pain was beginning to make me hobble and I was about to learn a new word: podiatry.

My podiatrist, a tower of a man who wears disconcertingly orange clogs with his blue surgical jump suit, eased me into the wonderful world of podiatry.

"No surgery, yet, Matt. Foot surgery is a serious business… we'll give you some orthotics first."

These specially moulded soles were the most expensive shoes I have ever bought and they didn't work. Six months later the pain was so bad that I had to go under the knife.

I would like to say that I have joined the hallowed order of the broken metatarsal, just in time for the World Cup.

Rooney, Beckham, Owen, Frei… even if I was nursing MY metatarsal on the sofa watching them test theirs on the pitch. But unfortunately I shared my pain with the other Beckham, not David, Victoria.

And it wasn't the metatarsal per se… it was metatarsal-related. I am talking about an excrescence of the bone resulting in a serious realignment of the toes. I am talking about a… bunion.

Posh Spice has one, a whopper that sticks out of her golden lace thong sandals like a raw pink golf ball. And I have two. One on each foot.

Hobbling hordes

"Bunion?" Isn't that what women get for wearing the wrong shoes?" a friend asked. True.

About 50% of American women get bunions, a statistic that didn't make me feel any better. I owe mine to my mother. Yes, they are hereditary and no, I have never worn stilettos.

"Bunion?" I asked the doctor. "Is there no fancier word? Something in Latin perhaps. Something complicated, more interesting?"

"Well, bunion is the ancient Greek word for turnip. Does that help?" the doctor with the orange clogs asked. (*)

No, it didn't.

The worst thing is that the surgery necessary to remove a "turnip" is long, complicated, painful and could end in failure.

It involves hobbling around for eight weeks with a surgical boot that could have been invented by a workshop of medieval torturers on attachment to the Ministry of Funny Walks.

I hit my low point last week. I was waiting in the surgery for my post operation check-up.

I was surrounded by middle-aged women wearing the same boot. My fellow patients. The hobbling regiment of hop-alongs.

A lady with a magenta rinse turned to me and said: "Honey, I feel so sorry for you. You are the wrong age and the wrong gender to have a bunionectomy!"

She recommended I check out an internet talk show called Life Beyond Bunions. I didn't know whether to feel flattered or flattened.

*bunion: medical condition known as hallux valgus. Origin early 18th century, unknown origin, perhaps Old French buignon, from buigne, bump on the head (Oxford English Dictionary)

Send us your comments on this week's Washington Diary


This is a part of article Washington diary: Body shock Taken from "Comparison Levitra Viagra" Information Blog

Pulmonary Hypertension in Interstitial Lung Disease

Treatment of Pulmonary Hypertension in Interstitial Lung Disease

Limited data suggest that the treatment of pulmonary hypertension in ILD is beneficial. Enough oxygen to limit exercise and nocturnal hypoxemia should be a focus of care.

Trakada et al.[11] studied 38 patients with ILD and oxygen saturation above 90% at rest during the daytime with nocturnal polysomnography. They observed that all 38 (100%) experienced nocturnal hypoxemia to an oxygen saturation at least below 85%, and they suggested that screening for nocturnal hypoxemia should be standard in these diseases.

There are some theoretic risks to vasodilation in patients with ILD. If pulmonary artery vasodilation leads to improved blood flow into areas of fibrotic lung, then worsening of ventilation perfusion mismatch may result. This would be manifested by lower oxygen concentrations either at rest or with activity. Whether significant worsening of hypoxemia occurs with oral or systemic vasodilators remains to be shown in larger clinical trials. Small studies have suggested that hypoxemia may occur. This has been shown in some scleroderma patients with ILD who were treated with epoprostenol.[15] Ghofrani et al.[16] administered inhaled nitric oxide, intravenous epoprostenol, or oral sildenafil to 16 patients with pulmonary hypertension and ILD. Although all three agents decreased pulmonary vascular resistance, the patients receiving intravenous prostacyclin experienced decreased arterial oxygen tension, largely because of an increase in shunt fraction. By contrast, inhaled nitric oxide and sildenafil maintained ventilation perfusion matching and decreased pulmonary vascular resistance without a decrease in arterial oxygen tension.

There is a theoretic benefit in matching ventilation and pulmonary vasodilation with an inhaled medication such as iloprost. In a pilot study by Olshewski et al.,[17] eight patients with ILD and severe pulmonary hypertension were given epoprostenol, inhaled nitric oxide, or inhaled iloprost. Systemic arterial pressure, arterial oxygen saturation, and pulmonary right-to-left shunt flow, measured by multiple inert gas analysis, were not significantly changed; however, pulmonary vascular resistance fell and was associated with significant clinical improvement in some of the patients.

The advancement of therapies for pulmonary hypertension in ILD will require carefully designed clinical trials that will focus on both short-term and long-term endpoints. Although survival may ultimately be affected, short-term studies of gas exchange, exercise tolerance, and quality of life should be sufficient to speed therapies to the bedside of these difficult-to-treat patients.  Printer- Friendly Email This

Curr Opin Pulm Med.  2005;11(5):452-455.  ©2005 Lippincott Williams & Wilkins
This is a part of article Pulmonary Hypertension in Interstitial Lung Disease Taken from "Comparison Levitra Viagra" Information Blog

Mobile Cardiac Outpatient Telemetry for the Diagnosis of Presyncope/syncope

Results

MCOT was used to evaluate palpitations in 76 patients, syncope/presyncope in 17 patients, and to determine outcome of therapy in 29 patients. The baseline characteristics for each group are provided in Table 1 . Overall, the mean age was 58 ± 17 years and 57% were women. Structural heart disease was present in 33 patients (27%). Evaluation of Symptoms (Table 2)

Palpitations. Of 18 patients without a previous arrhythmia diagnosis, 14 (73%, +/+) reported symptoms during monitoring, all of whom had a diagnostic arrhythmia. Two of the 14 patients also had an autodetected asymptomatic arrhythmia (VT-NS and Brady). Recorded symptomatic arrhythmias included: PVCs (n = 7); ST (n = 3); Brady (n = 2); SVT (n = 1); and PACs (n = 1). One of four asymptomatic patients (-/+) had an autodetected VT-NS during monitoring.

Fifty-eight patients had previously been diagnosed with an arrhythmia using another monitoring system. Previously documented arrhythmias included: PAF (n = 26); PSVT (n = 17); AT (n = 4); VT-NS (n = 6); AFl (n = 2); inappropriate ST (n = 2); and PACs (n = 1). During the MCOT monitoring period, 34 (59%) patients experienced recurrent palpitations. In this symptomatic group of 34 patients, 27 patients (+/+) had a documented arrhythmia and seven patients (±) had no arrhythmia correlating to their palpitations. Of the patients with a symptomatic arrhythmia (+/+), two also had PSVT as an autodetected asymptomatic arrhythmia. Detected symptomatic arrhythmias included: PAF (n = 10); ST (n = 4); PVCs (n = 4); AT (n = 4); PSVT (n = 3); AFl (n = 2); PACs (n = 2); and VT-NS (n = 1). Interestingly, the documented arrhythmia was often different (nine of 27) from the previously detected symptomatic arrhythmia (Fig. 1). Furthermore, one patient had AF detected as the likely initiating arrhythmia for AFl (Fig. 2). Of the seven patients with symptoms but no documented arrhythmia (±), one had autodetected asymptomatic VT-NS. The remaining 24 (41%) patients in this group with a previously diagnosed arrhythmia were asymptomatic; however, 15 (-/+) had an autodetected arrhythmia during MCOT monitoring. Patients with autodetected arrhythmias included: AF (n = 7); VT-NS (n = 5); Brady (n = 3); AFl (n = 2); and PSVT (n = 1). Two of the 15 had at least two different autodetected asymptomatic arrhythmias.

Figure 1.  (click image to zoom)

Symptomatic and asymptomatic arrhythmias in patients with palpitations and previously diagnosed arrhythmias. Note that many patients with a documented arrhythmia have a different arrhythmia on subsequent analysis.      

Figure 2.  (click image to zoom)

Tachycardia-induced tachycardia. Palpitations initially occurred during the onset of atrial fibrillation (A), which subsequently induced atrial flutter (B).      

There were 36 episodes of AF/AFl, 22 episodes of bradycardia/pauses, six episodes of NSVT, and one episode of PSVT. The mean ventricular rate of the AF/AFl was 103 ± 27 bpm with a mean duration of 10.7 ± 14.1 hours. The PSVT lasted <1 minute at a rate of 175 bpm. Most of the asymptomatic arrhythmia episodes occurred between 10 PM and 6 AM: AF/AFl (n = 17, mean duration 7 ± 10.7 hours), Brady (n = 13), and PSVT. The second most frequent time to have an asymptomatic episode was 6 AM to 2 PM; AF/AFl (n = 12, mean duration 16.6 ± 18.4 hours), Brady (n = 7), and NSVT (n = 6). The least common interval to have an asymptomatic arrhythmia was 2 PM to 10 PM; AF/AFl (n = 7, mean duration 11.5 ± 13.6), and Brady (n = 2).

Syncope. Ten of 17 (59%) patients evaluated for presyncope/syncope had their typical symptoms during monitoring. Five of the symptomatic patients (+/+) had an arrhythmia documented: Brady (n = 2); AVB-2 (n = 1); VT-NS (n = 1); and PVCs (n = 1). In addition, three patients had autodetected asymptomatic arrhythmias (PAF in two and VT-NS in one). Of the remaining seven asymptomatic patients (-/+), three had autodetected arrhythmias (VT-NS in two patients and AF, AVB-2, and VT-NS in one patient). Mean time to patient-activated first event was 3.7 ± 4.2 days.

Previous Negative Evaluation. Fourteen of the patients being evaluated for palpitations (n = 6) and presyncope/syncope (n = had a previous negative arrhythmia workup ( Table 3 ). Electrophysiology study, Holter monitor, event monitor, or tilt table testing was performed in six, five, three, and one patient, respectively. MCOT was diagnostic in all six patients with palpitations: PVCs (n = 2); PSVT (n = 1); Brady (n = 1); PACs (n = 1); and ST (n = 1). Five of the eight patients with a previous negative evaluation being re-evaluated for presyncope/syncope had their symptoms during MCOT monitoring: SR in three and Brady in two. Both Brady patients had prolonged pauses (>4 seconds) that were directly related to their symptoms (Fig. 3).

Figure 3.  (click image to zoom)

Presynope associated with a long pause after termination of atrial fibrillation.      

Evaluation of Therapy

Twenty-nine patients were prescribed MCOT to evaluate therapy efficacy, 21 for medication titration, and eight following radiofrequency ablation. Ventricular rate control of AF (n = 10) and AT (n = 4) was monitored with MCOT in 14 patients using AV nodal blocking drugs. The AV nodal blocking medications utilized included: beta-blockers (n = 10); digoxin (n = 5); and calcium channel blockers (n = 5). Seven patients required further medication titration for adequate ventricular rate control, which was accomplished in the outpatient setting with continued MCOT monitoring. Two patients treated for rate control of AF developed symptomatic prolonged pauses (up to 6.5 seconds) that MCOT monitoring documented, the drug doses were promptly changed, and the patients had no adverse consequences. Both patients ultimately underwent permanent pacemaker implantation for tachycardia-bradycardia syndrome. One patient with a history of poorly controlled hypertension and bradycardia was monitored with MCOT for beta-blocker initiation. Adequate blood pressure control was obtained without a recurrence of bradycardia. Six patients were monitored with MCOT for attempted rhythm control using antiarrhythmic medications: four with AF; one with VT-NS; and one with PVCs. Antiarrhythmic medications used for rhythm control in these patients included amiodarone (n = 6), sotalol (n = 3), propafenone (n = 1), and mexiletine (n = 1).

Eight patients underwent MCOT monitoring following radiofrequency ablation for AF (n = 5), AFL (n = 1), PVCs (n = 1), and inappropriate ST (n = 1). Two patients experienced symptoms during MCOT monitoring. One patient experienced symptomatic PACs and the other had SR during their symptomatic episode. There was one occurrence of asymptomatic AF in a patient following radiofrequency ablation of AF.  Printer- Friendly Email This

J Cardiovasc Electrophysiol.  2007;18(5):473-477.  ©2007 Blackwell Publishing
This is a part of article Mobile Cardiac Outpatient Telemetry for the Diagnosis of Presyncope/syncope Taken from "Amiodarone 200Mg" Information Blog

Reduction of High-Risk Polypharmacy Drug Combinations

Abstract and Introduction

Abstract

Study Objectives: To enhance physician and patient awareness of polypharmacy; to decrease the risks, drug costs, and waste resulting from polypharmacy; and to make the business case for reducing misuse, overuse, and underuse of drugs by reducing polypharmacy.
Design: Longitudinal, time series cohort.
Setting: Outpatient, managed care, integrated delivery system.
Patients: A total of 195,971 patients who received health care from the Henry Ford Medical Group and had health insurance coverage from the Health Alliance Plan.
Measurements and Main Results: Two identical interventions separated by 1 year were conducted in patients at high risk of harm from polypharmacy based on five categories of high-risk drug combinations (referred to as polypharmacy events). Six months of pharmacy claims data were reviewed before and after each intervention to identify these patients. The intervention program consisted of clinical pharmacists performing drug therapy reviews, educating physicians and patients about drug safety and polypharmacy, and working with physicians and patients to correct polypharmacy problems. Prescription cost/member/month, number of prescriptions/member/month, and rates of polypharmacy events/1000 members were measured before and after each of the two interventions. After the first intervention, the overall rate of polypharmacy events decreased from 29.01 to 9.43/1000 patients (67.5% reduction). The number of prescriptions/member/month decreased from 4.6 to 2.2 (52.2% reduction), prescription cost/member/month decreased from $222 to $113 (49.1% reduction), and overall institution drug cost was reduced by $4.8 million. Six months after the second intervention, the overall rate of polypharmacy events was reduced from 27.99 to 17.07/1000 (39% reduction), the number of prescriptions/member/month decreased from 4.5 to 4.0 (11.1% reduction), and prescription cost/member/month decreased from $264 to $239 (9.5% reduction). Overall institution drug costs were reduced by $1.3 million. Sustained effects were seen for all measures of polypharmacy (p=0.001).
Conclusions: These interventions reduced drug costs and numbers of prescriptions in a managed care cohort of patients at high risk for adverse drug events due to polypharmacy. By providing clinical information, decision support, patient self-management support, and care delivery redesign some of the problems resulting from polypharmacy can be solved.Introduction

A national survey of noninstitutionalized American adults indicated that more than 40% of persons aged 65 years or older take five or more different drugs/week, with 12% taking 10 or more.[1] Polypharmacy, however, may not only be appropriate but is often necessary to improve health outcomes and prevent disease progression in older persons with chronic conditions. However, overuse, underuse, and misuse of drugs have all been linked to serious health problems, disabilities, hospitalizations, and death.[2-4]

The term polypharmacy suggests that more drugs are prescribed and taken than are warranted clinically. Patients at greatest risk of polypharmacy consequences are the elderly, patients taking five or more concurrent drugs, those with multiple physicians and pharmacies, patients with concurrent comorbidities or impairments in vision or dexterity, and individuals who have recently been hospitalized.[5] According to one study, nearly one in four noninstitutionalized elderly Americans is taking potentially dangerous prescription drugs.[3]

Researchers who evaluated a cohort of older ambulatory persons estimated that as many as 27.6% of adverse drug events are preventable and occur most commonly with cardiovascular drugs, diuretics, nonopioid analgesics, antidiabetic agents, and anticoagulants.[6] Preventable drug-related morbidity is the fifth most costly health condition. In 2000, the United States spent $133 billion on drugs and an estimated $177 billion managing drug-related problems.[7] For every $1.00 spent on drug therapy, as much as $1.30 may be spent managing drug-related problems.[7] These concerns have prompted calls to action by numerous organizations, including the Centers for Medicare and Medical Services, the Institute for Health Care Improvement, the Institute for Health Care Quality, the National Committee for Quality Assurance, the National Quality Forum, and the Institute for Safe Medication Practices. Oversight of pharmaceutical care by clinical pharmacists has proven effective in improving quality and lowering cost of care in various venues.[8-14]

The goal of our longitudinal study was to improve drug safety through the reduction of polypharmacy in managed care patients. In patients receiving polypharmacy, we performed two identical interventions that consisted of clinical pharmacists performing drug therapy reviews, educating physicians and patients about drug safety and polypharmacy, and working with physicians and patients to correct polypharmacy problems. The intervention integrated the practice of pharmaceutical care with data extracted from pharmacy claims. Primary objectives were to enhance physician awareness of polypharmacy within our managed care network, decrease rates of selected high-risk polypharmacy combinations, and reduce drug costs resulting from polypharmacy.

Our secondary objective was to develop the business case for expanding the polypharmacy intervention program to all patients receiving health coverage from our institution. According to some authors, an intervention can be said to fulfill a business case for quality if it leads to a financial return on the investment needed to implement the intervention in a reasonable time and with a reasonable rate of discounting.[15] This return may consist of profit, reduced losses, or avoided costs. For a polypharmacy intervention to be sustainable, it must satisfy the business case for quality.  Printer- Friendly Email This

Pharmacotherapy.  2005;25(11):1636-1645.  ©2005 Pharmacotherapy Publications
This is a part of article Reduction of High-Risk Polypharmacy Drug Combinations Taken from "Comparison Levitra Viagra" Information Blog

Levitra May Protect The Heart, VCU Study Shows

The widely used erectile dysfunction drug Levitra is now the ware drug in its aggregation found to protect the area against tissue paper legal injury movement acute two-dimensional figure military operation, according to a new examination by Old Dominion Nation Educational institution researchers.

“Our findings further influence the concept that the fiction form of phosphodiesterase-5 inhibitors, or PDE-5 inhibitors, including cheap generic levitra and viagra, may have a new service in cardiac protective covering, in summation to their well-known use for the governance of erectile dysfunction in men,” said Rakesh C.
Kukreja, Ph.D., professor of medical science, bodily property, biochemistry and emergency brake music at VCU.
Kukreja is lead communicator of the engrossment.

In the field, currently available online and to be published in the Mar way out of the Leger of Molecular and Cellular Cardiology, Kukreja and his team demonstrated for the gear mechanism time that pretreatment with a clinically relevant dose of Levitra, generically known as vardenafil, induces a protective upshot against area approach unhealthiness by passageway the mitochondrial KATP depression in an animal theory.
The Periodical of Molecular and Cellular Cardiology is the skilled worker work of the International Smart set for Philia Problem solving.

According to Kukreja, PDE-5 is an enzyme responsible for the conclusion of cGMP, an intracellular messenger stuff, in center cells.
He said that the mitochondrial KATP passage and cGMP play an important role in preconditioning of the sum the great unwashed a courageousness flak.
The cGMP also has a hand in the discussion of arteries in the body.
PDE-5 inhibitor drugs, such as vardenafil, sildenafil, the ware term for sildenafil, and cialis, the ware name for cialis, are able to sphere cGMP, and therefore treatment of the arteries by inhibiting PDE-5.

Vardenafil, like viagra, stabilizes the mitochondria and protects against alteration of the courageousness by entry the mitochondrial KATP channels in cardiac cells.
Mitochondria are cellular organelles critical for converting oxygen into ATP, the key fuel for cellular relation.

“This report provides important message about the mechanics by which the PDE-5 inhibitors work.
Furthermore, it is argument that the photographic film findings of prior studies on viagra extend to another PDE-5 inhibitor,” said George VI Vetrovec, M.D., seat of cardiology at VCU’s Schooltime of Music, who is internationally recognized for his inquiry on coronary arterial blood vessel disease.

Vetrovec suggested that PDE-5 inhibitors such as sildenafil and vardenafil may one day be given to patients who are at high risk for acute temperament military operation or prior to undergoing coronary blood vessel highway surgical procedure to optimize eye indorsement.

In summation, Kukreja said that the PDE-5 inhibitors may be developed for trade good use to protect the learning ability, somebody and other organs against ischemic ill health — those injuries that are caused by lack of oxygen.

Kukreja and his colleagues began studying viagra in 2002 as part of ongoing enquiry into “preconditioning,” a way to protect the warmness brawn from serious price in the trade good by subjecting it to very abstract periods of neediness of humor flow and, therefore, oxygen.
This is a part of article Levitra May Protect The Heart, VCU Study Shows Taken from "Comparison Levitra Viagra" Information Blog

Attention!

Attention! Brand new sites for all amateurs and adult porn tube lovers!

Long-term Tolerance With Viagra

Doubtfulness

Is there any indication that there is mental attitude or habituation when sildenafil is used over long periods of time?

Reaction from Thespian J.
G. Hellstrom, MD, FACS
Professor of Urology

Erectile dysfunction (ED) is defined as the unfitness to attain or maintain an adequate penile building for satisfactory sexual sexual congress. Since the making known into clinical noesis of viagra (sildenafil; Pfizer Pharmaceutical Corp.; New York, NY), there has been a dramatic action in the artistic style algorithm for men with ED.
No longer do all men wretchedness from ED have to repair to the surgical positioning of a penile prosthesis, intracavernosal injections or transurethral insertions of vasoactive agents, or household appliance tumescence devices in ordering to sum-up sexual relations.
Numerous placebo-controlled clinical ED studies lasting less than 1 year have documented the rubber and efficacy of sildenafil in patients with ED of various etiologies.

An unanswered subject in warmness to long-term sildenafil use is that of tachyphylaxis, a pharmacokinetic procedure in which paper sensitiveness to a drug diminishes.
A corresponding writing by El-Galley and colleagues published in 2001 reported that viagra produced tachyphylaxis, since 20% of the patients who were followed for 2 time of life needed increased dosages and 17% discontinued management because of the eventual lack of efficacy.

The results of the El-Galley domain were largely discounted upon poor follow-up; 50% of the men on sildenafil did not respond to a telecom interrogation at 2 years’ follow-up.
In direct contrast, a 3-year follow-up immersion in nerve-sparing measure prostatectomy patients (n = 41) revealed that 71% (29/41) were setup responding to the same dose of sildenafil. Of the 29% of dropouts, half (6/12) stopped because of key of spontaneous erections, with only 5 of 12 gradually losing efficacy.
Hence, most authorities have attributed loss of viagra efficacy not to tachyphylaxis, but to progress in organic disease from associated comorbidities and biological process.

However, a recent musing using cultured rat cavernosal smooth hooligan cells demonstrated molecular upregulation of the phosphodiesterase type 5 (PDE-5) enzyme when the cells treated with high doses of viagra for at least 7 days. These findings suggest that viagra is safe and effective when used at normal clinical doses and recommended dosing frequencies.
However, additional clinical investigation will be needed to evaluate the tachyphylaxis significance in chronic PDE-5 inhibitor use, especially when these agents possess long half-lives.

This is a part of article Long-term Tolerance With Viagra Taken from "Comparison Levitra Viagra" Information Blog